Fibroblast Activation Protein Imaging, An Issue of PET Clinics: The Clinics: Radiology, cartea 18-3
Editat de Frederik L. Giesel, Rodney Hicks, Ken Herrmannen Limba Engleză Hardback – 31 mai 2023
Din seria The Clinics: Radiology
- 5%
Preț: 461.31 lei - 5%
Preț: 460.31 lei - 5%
Preț: 461.88 lei - 5%
Preț: 460.88 lei - 5%
Preț: 657.81 lei - 5%
Preț: 420.62 lei - 5%
Preț: 686.42 lei - 5%
Preț: 685.40 lei - 5%
Preț: 687.73 lei - 5%
Preț: 549.30 lei - 5%
Preț: 577.74 lei - 5%
Preț: 687.00 lei - 5%
Preț: 548.04 lei - 5%
Preț: 577.05 lei - 5%
Preț: 577.64 lei - 5%
Preț: 576.48 lei - 5%
Preț: 576.54 lei - 5%
Preț: 576.79 lei - 5%
Preț: 577.52 lei - 5%
Preț: 605.40 lei - 5%
Preț: 577.71 lei - 5%
Preț: 577.17 lei - 5%
Preț: 576.53 lei - 5%
Preț: 680.28 lei - 20%
Preț: 395.76 lei - 5%
Preț: 745.33 lei - 21%
Preț: 330.74 lei - 5%
Preț: 789.90 lei - 5%
Preț: 743.81 lei - 5%
Preț: 744.05 lei - 5%
Preț: 743.48 lei - 5%
Preț: 745.45 lei - 21%
Preț: 390.20 lei - 28%
Preț: 366.05 lei - 21%
Preț: 364.73 lei - 21%
Preț: 366.52 lei - 24%
Preț: 351.56 lei - 21%
Preț: 362.45 lei - 21%
Preț: 384.39 lei - 21%
Preț: 384.39 lei - 24%
Preț: 350.16 lei - 20%
Preț: 369.72 lei - 5%
Preț: 369.17 lei - 20%
Preț: 368.31 lei - 5%
Preț: 387.04 lei - 5%
Preț: 387.04 lei - 28%
Preț: 365.82 lei - 25%
Preț: 377.16 lei - 20%
Preț: 396.65 lei
Preț: 461.30 lei
Preț vechi: 485.57 lei
-5% Nou
Puncte Express: 692
Preț estimativ în valută:
88.31€ • 92.14$ • 74.03£
88.31€ • 92.14$ • 74.03£
Carte disponibilă
Livrare economică 20 februarie-06 martie
Livrare express 05-11 februarie pentru 37.33 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323938952
ISBN-10: 0323938957
Pagini: 240
Dimensiuni: 178 x 254 x 18 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Radiology
ISBN-10: 0323938957
Pagini: 240
Dimensiuni: 178 x 254 x 18 mm
Greutate: 0.54 kg
Editura: Elsevier
Seria The Clinics: Radiology
Cuprins
Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements
Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer
Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer
Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer
Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma
Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor
Imaging Fibrosis
Cardiac Applications of Fibroblast Activation Protein Imaging
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation
Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions
Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma
Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer
Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer
Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer
Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma
Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor
Imaging Fibrosis
Cardiac Applications of Fibroblast Activation Protein Imaging
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation
Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions